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The Total Market Approach (TMA) leverages the 
comparative advantages of  all market sectors to enhance 
equitable and sustainable family planning (FP) across 
market segments, with government coordination and 
support. It is based on an understanding that equitably 
meeting the diverse needs of  different population 
segments requires increased coordination across 
sectors, including the public, private for-profit, and 
not-for-profit sectors. This is particularly important in 
the context of  global commitments to increase access 
to family planning, including the FP2020 goal of  
reaching 120 million additional women by 2020.
According to the 2016 Performance Monitoring and 
Accountability (PMA) 2020 Detailed Indicator Report, 
the modern contraceptive prevalence rate (mCPR) 
in Uganda is 27.5% for all sexually active women, 
ages 15 to 49, and 32.2% for married women. The 
PMA 2020 report found that injectables are the most 
popular method, used by more than half  of  married 
contraceptive users. See Figure 1 for a breakdown of  
Uganda’s method mix.
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FIGURE 1 .  CURRENT MODERN METHOD MIX 
AMONG MARRIED CONTRACEPTIVE USERS
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Percent of facilities offering 
contraceptive products
The Ugandan public health system is divided into five 
different levels encompassing national and district levels 
(see Box 1). The retail audit collected and analyzed data 
from facilities at each level. 
The methods stocked or sold by the highest number 
of  facilities were male condoms, combined oral 
contraceptive pills, and progesterone-only injectables. 
Although this pattern was similar across nearly all 
facilities, the percent of  facilities stocking or selling 
each method differed by facility type. Ninety percent of  
all facilities stocked or sold male condoms, though this 
ranged from 74% (Health Center II facilities) to 93% 
(drug shops). The percentage of  all facilities that stocked 
or sold pills was 63%, with a range of  23% (VHTs / 
Health Centre I) to 87% (registered pharmacies). Nearly 
half  (49%) of  all facilities stocked or sold progesterone-
only injectables, with a range of  27% (VHTs / Health 
Center I) to 74% (Health Centre II). Levonorgestrel 
IUDs were the least likely method to be stocked or sold 
by any facility, across all categories (stocked or sold by 
less than 1% of  all facilities). 
The lowest rung is made up of Village Health 
Teams (VHTs, also referred to as Health Centre 
I). Health Centre II is the second-lowest level, 
comprising outpatient services provided by 
nurses. Health Centre IIIs offer additional ser-
vices, including in-patient and maternal health 
treatment. Health Centre IVs are staffed by 
medical doctors and offer a variety of in- and 
out-patient services. Finally, public hospitals 
are considered the highest level and are divid-
ed into three groups: general hospitals, region-
al referral hospitals, and national referral hos-
pitals. Regional and national referral hospitals 
have been combined into one group for the pur-
poses of data analysis, while private hospitals 
are aggregated with general hospitals.
LEVELS OF UGANDAN HEALTH 
FACILITIES
BOX 1
Study Design
This brief  is based on a retail audit, carried 
out in January 2016, that was commissioned 
as part of  PATH’s work under the USAID-
funded Evidence Project to conduct a landscape 
assessment of  the feasibility of  a Total Market 
Approach in Uganda. This project also involved 
key informant interviews with stakeholders on 
their attitudes towards TMA principles and the 
collection of  a Uganda Market Research Summary 
of  existing FP knowledge. In the retail audit, 
stratified random sampling was used to select 
outlets for evaluation from a sampling frame of  
187,580 outlets, consisting of  health facilities, 
pharmacies, drug shops, and village health teams 
(VHTs). The sample was split across regions, 
based on the percentage of  total outlets in each 
region. Kampala was treated as a separate region, 
since it has a disproportionately high number of  
outlets (27% of  the total number of  outlets in 
Uganda). Districts were randomly selected from 
within each region, and outlets were randomly 
selected to meet the quota per district and quota 
per region. A total representative sample of  
664 outlets was identified, distributed across 
the regions as follows: Kampala (27%), Central 
(16%), Northern (15%), Eastern (20%), and 
Western (22%). Data was collected on: 
 ▪ Percentage of  outlets that report having 
stock of  or selling contraceptive methods. 
(Note: data was collected separately for contraceptive 
methods stocked and contraceptive methods sold, so 
these measures are reported separately here.)
 ▪ Product demand, according to outlet 
managers.
 ▪ Most frequently cited factors affecting 
client’s purchase of  contraceptive products, 
according to outlet managers.
 ▪ Most common retail price points for 
contraceptive products.
 ▪ Percentage of  outlet managers reporting a 
stock out (among outlets that responded to 
the question regarding stock outs).
 ▪ Distribution of  stock out times.
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Referral hospitals showed a slightly different pattern: 
male condoms were the most commonly stocked 
or sold method among these facilities, but this was 
followed by implants and copper IUDs (both of  which 
were stocked or sold by fewer outlets in other facility 
categories). Registered pharmacies also deviated from 
the overall trend, with emergency contraception being 
the third most commonly stocked or sold method at 
facilities in this category. 
The proportion of  facilities stocking and selling 
particular methods is often tied to characteristics of  
the method. For example, VHTs often provide health 
services to rural villages and areas that have limited 
storage or transportation capacity, and male condoms 
are the most frequently stocked or sold product at 
this level, with the next most common commodities 
(injectables and pills) stocked or sold by only around 
one quarter of  VHTs. And a high percentage of  
registered pharmacies stocked or sold male condoms, 
combined pills, and emergency contraception, but very 
few of  these facilities stocked or sold IUDs or implants, 
which require trained providers and additional medical 
supplies that pharmacies are less likely to have.
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FIGURE 1 | PERCENT OF HEALTH CENTRE FACILITIES REPORTING STOCK OR SALES OF CONTRACEPTIVE PRODUCTS
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FIGURE 2 | PERCENT OF PRIVATE RETAILERS REPORTING STOCK OR SALES OF CONTRACEPTIVE PRODUCTS
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Most frequently cited factor 
affecting purchase
The factors that outlet managers think influence 
their clients’ choice of  contraceptive method may 
consequently influence what outlet managers then 
decide to stock. Facility managers were asked “what 
do you think is the most frequently cited factor that 
influences the purchase of  a contraceptive method?” 
In general, avoidance of  perceived side effects was the 
most commonly cited factor, with knowledge/familiarity 
with the brand and the low price of  the product cited 
slightly less commonly. Duration of  the method, brand 
visibility, and “promotion” of  the brand (i.e. whether it 
is on sale) were the least frequently mentioned. 
With managers responding that neither the low price of  
the brand nor its perceived quality have much influence 
on clients’ purchase decisions, commercial sector 
managers could market their products more effectively 
by considering clients’ concerns about side effects and 
levels of  knowledge or familiarity with the product, 
the two most influential factors (e.g. emphasizing that 
a certain type of  injectable is known to have fewer 
side effects). In addition, the relatively high percentage 
for access and availability for implants suggests that 
the need for administration by a trained provider is a 
barrier to use.
Analysis of retail price points
Mapping the range of  price points for different 
contraceptive methods, including products that are 
available for free or at an artificially low cost, allows 
TMA planners to know which sectors are the primary 
providers of  specific methods and to set appropriate 
price points. Identifying the most common price points 
for different contraceptive methods allows TMA 
planners to help outlet managers know where to set 
their prices to remain viable. Noting the presence of  
free or artificially low price points helps to identify 
which products come from the public or social 
marketing sectors. 
219 facilities sold social marketing agency-branded 
condoms; these condoms (available in packs of  three) 
were most commonly sold for 1,000, 2,000, and 3,000 
UGX (US$0.30 to $1.00), although the fourth most 
common price point was 0 UGX. Since social marketing 
products are typically sold for a (often low) fee, the 
availability of  these condoms for free suggests that 
retail outlets may have obtained these products from 
a third-party outlet, rather than directly from the social 
marketing agency. Fewer facilities sold non-subsidized, 
commercial condom brands (18 facilities sold Durex, 57 
facilities sold Contempo), with greater price variation 
(1,000 to 82,500 UGX for a three-pack of  Contempo 
condoms and 1,000 to 15,000 
UGX for Durex condoms).
Of  401 facilities that carry 
combined oral contraceptives 
(COC), 31% provide them 
for free, which indicates the 
significant influence in the 
Ugandan market of  the free 
provision of  contraceptives 
by the public sector and the 
government. Among consumers 
who pay for COCs, 1,000 UGX 
($0.30) is the most common price. 
Progesterone-only pills (sold by 
44 facilities) follow a similar trend 
with free, presumably public 
sector-provided product being 
most common and 1,000 UGX 
and 3,000 UGX being the top two 
most frequently charged prices. 
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Of  the 59 facilities that carry implants, 371 facilities that 
carry injectables, and 89 facilities that carry IUDs, the 
majority offer these commodities for free (66%, 50%, 
and 55% respectively). When not free, prices charged 
for these methods vary greatly: implants range from 
1,000 to 100,000 UGX (with no price most common); 
injectables were most often priced at 2,000 (8%), 3,000 
(5%), and 1,000 (5%) UGX; and IUDs - typically the 
most expensive of  the three – most often cost 20,000 
UGX (US$5.90) and 10,000 UGX (US$3.00). That a 
majority of  these facilities offer these commodities for 
free suggests that the public sector is the primary source 
for implants, IUDs, and injectable products and services. 
Emergency contraception is available at a wide range of  
prices, but the most common price is overwhelmingly 
10,000 UGX (approximately US$3.00). Emergency 
contraception is also widely available for free; the fact 
that free was not the most common price (as it is for 
implants, pills, injectables, and IUDS) may be due to the 
fact that it is a more expensive product and is thus not 
purchased at as high a rate by the public sector as other 
products. In addition, many users do not plan in advance 
to use emergency contraception and may therefore be 
more willing to pay to obtain it quickly, feeling that the 
extra time required to get it for free isn’t worth it. 
The preponderance of  contraceptive 
products being distributed for free, 
especially pills and injectables, indicates 
the extent to which public sector-
provided commodities dominate the 
market in Uganda. A next step would 
be to conduct market segmentation and 
willingness/ability to pay studies to more 
accurately determine the characteristics 
of  clients accessing these products. 
However, the sheer amount of  free 
product being distributed means that 
some users will inevitably use these free 
methods, even if  they have the means 
to purchase the product. This points 
to the need to encourage eligible users 
to move up the value chain to products 
they are willing and able to pay for and 
leave the free product to users without 
the means to pay for contraception. 
Stockouts
Outlet managers were asked about each brand of  
each type of  contraceptive method and whether they 
were experiencing a stockout  at their facility. Among 
facilities that responded, one or more brands of  pills, 
male condoms, and emergency contraception were 
out of  stock. Stockouts seem to be most prevalent for 
products for which there are multiple brands, such as 
pills and condoms. There are not typically many brands 
of  emergency contraception, and the high percentage 
of  stockouts for that method may be because facilities 
carry small amounts due to low demand (emergency 
contraception is used by only 0.3% of  contraceptive 
users in Uganda). Of  the facilities reporting stockouts, 
the majority of  stockouts of  injectables, emergency 
contraception, pills, and male condom brands lasted 
less than 30 days. 
The fact that there is a high rate of  stockouts among the 
most popular methods, and that those stockouts can 
sometimes continue for months at a time, is a concerning 
sign regarding the strength of  the contraceptive supply 
chain. Reducing the amount of  stockouts that occur, 
as well as speeding up the rate of  re-delivery, are two 
central areas where increased government stewardship 
could play a role.
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FIGURE 3 | PRODUCTS THAT WERE OUT OF STOCK IN FACILITIES THAT 
HAD REPORTED A STOCKOUT1
1 Stockout is defined here as having a quantity of  zero of  the brand of  product on the day the survey was conducted
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